Press Release: Affini-T : Affini-T Therapeutics Presents Preclinical Data from its Programs Targeting Oncogenic Drivers KRAS and TP53 at AACR

BOSTON, MA, UNITED STATES, April 24, 2025 /⁨EINPresswire.com⁩/ -- Affini-T Therapeutics to present data from pipeline programs targeting the cancer driver mutations KRAS G12V and TP53 R175H. Presentations will include real-world data on the low frequency ...